Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Bausch-Lomb-to-buy-dry-eye-drug-from-Novartis-for-1-75-billion-WSJ-44241095/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.